Evidence map›Paper›PMID 30709836›Full record

ArticleBMJ case reports2019

Rare cause of lung atelectasis in a young woman.

Paula Inês Pedro, Dolores Canário, Miguel Lopes, Despina Argyropoulou

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Case report: DynamicFrontiers in oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paula Inês PedroPulmonology, Hospital Garcia de Orta EPE, Almada, Portugal.
Dolores CanárioPulmonology, Hospital Garcia de Orta EPE, Almada, Portugal.
Miguel LopesPulmonology, Hospital Garcia de Orta EPE, Almada, Portugal.
Despina ArgyropoulouPathology, Hospital Garcia de Orta EPE, Almada, Portugal.
Hospital Garcia de Orta · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary mucoepidermoid carcinoma is an extremely rare intrathoracic malignancy, comprising less than 1% of all lung tumours. These are very slow growing and are classified into low grade and high grade based on histological features. Surgical resection is the primary treatment with excellent outcomes, while chemotherapy or radiotherapy effectiveness is not known. Preoperative fluorine-18 fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) is useful for predicting tumour grade and postsurgical prognosis.A clinical case of a 31-year-old woman who presented with dyspnoea on exertion, cough and wheezing is reported. Imaging studies revealed a mass involving the left lower lobe bronchus and atelectasis. 18F-FDG PET/CT showed uptake in the described mass with a maximum standardised uptake value of 9.7. Complete surgical resection was performed, and pathological examination revealed a high-grade mucoepidermoid carcinoma with tumour-free margins. Adjuvant chemotherapy was given and there is no evidence of tumour recurrence.

Indexed as

Antineoplastic Agents, PhytogenicBiopsyCarboplatinCarcinoma, MucoepidermoidChemoradiotherapy, AdjuvantFemaleHumansLung NeoplasmsPositron Emission Tomography Computed TomographyPulmonary AtelectasisThoracotomyTreatment OutcomeVinorelbineYoung AdultAntineoplastic Agents, PhytogenicCarboplatinVinorelbinepneumonia (respiratory medicine)respiratory cancer

Identifiers

PMID30709836
PMCPMC6357910
OpenAlexW2911919793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.